資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/31707
|
| 標題: | Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance |
| 作者: | Ku, Yee-Huang
Chen, Chi-Chung
Lee, Mei-Feng
Chuang, Yin-Ching
Tang, Hung-Jen
Yu, Wen-Liang |
| 貢獻者: | Chi Mei Med Ctr, Div Infect Dis, Dept Internal Med
Chi Mei Med Ctr, Dept Med Res
Chi Mei Hosp, Div Infect Dis, Dept Internal Med
Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr
Chi Mei Med Ctr, Dept Intens Care Med
Taipei Med Univ, Dept Med, Sch Med, Coll Med |
| 關鍵字: | Carbapenem resistance
Colistin
ESBL
Fosfomycin
Tigecycline |
| 日期: | 2017-12 |
| 上傳時間: | 2018-11-30 15:53:41 (UTC+8) |
| 出版者: | Elsevier Taiwan |
| 摘要: | Purpose: To investigate the synergistic and bactericidal effects of antimicrobial combinations of any two of colistin, fosfomycin and tigecycline against the nine extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae (KP) clinical isolates, including 4 carbapenem-susceptible strains and five imipenem and/or meropenem-resistant strains. Methods: In vitro synergism and bactericidal activity of combination of colistin, fosfomycin and tigecycline were evaluated by time-kill studies in standard inoculum of bacterial densities of a suspension containing 5 x 10(5) CFU/mL by using 1/2 x MIC for each alone, and both 1/2 x and 1/4 x MIC for any two drugs. The settings of low MIC dosing were allowed to rapidly survey the most active drug combination. Results: The most active combination group was colistin plus tigecycline, showing synergy in 8 isolates and bactericidal activities in 6 isolates by using concentrations of 1/2 x MIC and 1/4 xMIC, respectively. The least active combination was tigecycline plus fosfomycin, which showed synergy in only 4 isolates and no bactericidal activities by using concentrations of 1/2 x MIC and 1/4 x MIC, respectively. Conclusions: The combination of tigecycline and colistin may be considered as a last-resort approach to the ESBL-producing KP infections, especially those isolates with carbapenem resistance. Copyright (c) 2017, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. |
| 關聯: | Journal of Microbiology Immunology and Infection, v.50, n.6, pp.931-939 |
| 顯示於類別: | [保健營養系(所) ] 博碩士論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 1513 | 檢視/開啟 | | j.jmii.2016.12.008.pdf | | 1242Kb | Adobe PDF | 0 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
